Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study

计划入组 6 人 · 首次发布于 2019 年 2 月 18 日

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

计划入组 10,000 人 · 首次发布于 2018 年 8 月 6 日

University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)

计划入组 176 人 · 首次发布于 2009 年 10 月 14 日

AAV9-based gene replacement therapy (University of Texas Southwestern Medical Center)

Tat-beclin-1

RFT5-dgA Immunotoxin（The University Of Texas Southwestern Medical Center）

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

United States

THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

United States

UNIVERSITY OF NORTH TEXAS

United States

Perioperative IO/TKI Combo Shows Promise in Renal Cell Carcinoma

Andelyn Biosciences Partners with Drake Rayden Foundation to Manufacture AAV Gene Therapy for Rare NKH Disease

Tenaya Therapeutics' Gene Therapy TN-201 Shows Promise with Projected $165M Revenue for Cardiomyopathy Treatment